EMA confirms clots as ‘very rare’ AstraZeneca side effect

Author: 
AFP
article author: 
ID: 
1617806059491483800
Wed, 2021-04-07 14:31

THE HAGUE: The EU’s drug regulator said Wednesday that blood clots should be listed as a “very rare” side effect of the AstraZeneca coronavirus vaccine but that the jab’s benefits continue to outweigh the risks.
No specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune response, the European Medicines Agency (EMA) said.

Main category: 

Leave a Reply

Your email address will not be published. Required fields are marked *